- Report
- June 2022
- 110 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- June 2022
- 120 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 117 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- January 2022
- 110 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Report
- July 2023
- 117 Pages
Global
From €5185EUR$5,250USD£4,314GBP
€7407EUR$7,500USD£6,163GBP
- Report
- January 2024
- 200 Pages
Japan
From €3975EUR$4,025USD£3,307GBP
€5679EUR$5,750USD£4,725GBP
- Report
- January 2024
- 100 Pages
Japan
From €1314EUR$1,330USD£1,093GBP
€1877EUR$1,900USD£1,561GBP
- Report
- November 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Report
- August 2023
- 255 Pages
Global
From €6568EUR$6,650USD£5,465GBP
€9383EUR$9,500USD£7,807GBP
- Report
- August 2023
- 127 Pages
Global
From €3284EUR$3,325USD£2,732GBP
€4691EUR$4,750USD£3,903GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Report
- July 2023
- 58 Pages
Global
From €2731EUR$2,765USD£2,272GBP
€3901EUR$3,950USD£3,246GBP
- Report
- June 2023
- 159 Pages
Global
From €5185EUR$5,250USD£4,314GBP
€7407EUR$7,500USD£6,163GBP
- Report
- June 2023
- 80 Pages
Global
From €2731EUR$2,765USD£2,272GBP
€3901EUR$3,950USD£3,246GBP
- Report
- April 2023
- 224 Pages
Global
From €5185EUR$5,250USD£4,314GBP
€7407EUR$7,500USD£6,163GBP
- Report
- February 2023
- 198 Pages
Global
From €5185EUR$5,250USD£4,314GBP
€7407EUR$7,500USD£6,163GBP
- Report
- February 2023
- 99 Pages
Global
From €2731EUR$2,765USD£2,272GBP
€3901EUR$3,950USD£3,246GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- January 2023
- 30 Pages
United States
From €1901EUR$1,925USD£1,582GBP
€2716EUR$2,750USD£2,260GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2247EUR$2,275USD£1,869GBP
€3210EUR$3,250USD£2,671GBP
The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more